fluphenazine enanthate has been researched along with haloperidol in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Domino, EF | 1 |
| Walton, R | 1 |
| Rampertaap, MP | 1 |
| Furukawa, T; Yamada, K | 1 |
| Citrome, L; Jaffe, A; Levine, J | 1 |
| Den, R; Mimura, M; Sakurai, H; Suzuki, T; Tsutsumi, C; Uchida, H; Uchida, T | 1 |
1 review(s) available for fluphenazine enanthate and haloperidol
| Article | Year |
|---|---|
Neuroleptic malignant syndrome.
Topics: Adolescent; Adult; Benztropine; Bromocriptine; Catatonia; Child; Child, Preschool; Diagnosis, Differential; Female; Fluphenazine; Haloperidol; Heat Exhaustion; Humans; Male; Malignant Hyperthermia; Middle Aged; Neuroleptic Malignant Syndrome; Psychotic Disorders; Schizophrenia, Paranoid; Time Factors | 1986 |
7 other study(ies) available for fluphenazine enanthate and haloperidol
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Induction of tardive dyskinesia in Cebus apella and Macaca speciosa monkeys: a review.
Topics: Animals; Antipsychotic Agents; Benztropine; Cebus; Death, Sudden; Disease Models, Animal; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Fluphenazine; Haloperidol; Humans; Macaca; Male; Motor Activity; Stereotyped Behavior; Substance Withdrawal Syndrome | 1985 |
More than mere shots.
Topics: Chronic Disease; Communication; Fluphenazine; Haloperidol; Humans; Mental Disorders; Patient Care Team; Psychiatric Aides; Psychiatric Nursing | 1988 |
Catalepsy produced by long-acting neuroleptics, fluphenazine enanthate and fluphenazine decanoate, in mice.
Topics: Aminooxyacetic Acid; Animals; Antiparkinson Agents; Catalepsy; Delayed-Action Preparations; Drug Synergism; Enkephalins; Fluphenazine; Haloperidol; Humans; Male; Mice; Mice, Inbred Strains; Receptors, Dopamine | 1982 |
Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Drug Utilization; Female; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Kaplan-Meier Estimate; Length of Stay; Male; Microspheres; Middle Aged; Patient Discharge; Proportional Hazards Models; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2010 |
Ten year outcomes of outpatients with schizophrenia on conventional depot antipsychotics: a systematic chart review.
Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Drug Combinations; Female; Fluphenazine; Haloperidol; Humans; International Classification of Diseases; Longitudinal Studies; Maintenance Chemotherapy; Male; Medical Records; Medication Adherence; Middle Aged; Retrospective Studies; Schizophrenia; Secondary Prevention; Treatment Outcome | 2013 |